Assessment of bleeding events in clinical trials--proposal of a new classification
about
The safety of clopidogrel.Clinical review: bleeding - a notable complication of treatment in patients with acute coronary syndromes: incidence, predictors, classification, impact on prognosis, and managementDo gender differences in primary PCI mortality represent a different adherence to guideline recommended therapy? a multicenter observation.Bleeding avoidance strategies. Consensus and controversyLack of "obesity paradox" in patients presenting with ST-segment elevation myocardial infarction including cardiogenic shock: a multicenter German network registry analysisRisks and Benefits of Dual Antiplatelet Therapy Beyond 12 Months After Coronary Stenting: A Prospective Randomized Cohort StudyExpanding the recognition and assessment of bleeding events associated with antiplatelet therapy in primary care.Avoiding and managing bleeding complications in patients with non-ST-segment elevation acute coronary syndromes.Epidemiological Profile and Quality Indicators in Patients with Acute Coronary Syndrome in Northern Minas Gerais - Minas Telecardio 2 ProjectSafety and tolerability of antiplatelet therapies for the secondary prevention of atherothrombotic disease.Bleeding complications of unfractionated heparin.Advances in platelet function testing assessing bleeding complications in patients with coronary artery disease.Implications of an inpatient warfarin dosing nomogram on safety outcomes post-discharge.Periprocedural antiplatelet therapy: recommendations for standardized reporting in patients on antiplatelet therapy: communication from the SSC of the ISTH.Impact of Post-Exodontia Bleeding in Cardiovascular Patients: A New Classification Proposal.Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.Bleeding after expandable nitinol stent placement in patients with esophageal and upper gastrointestinal obstruction: incidence, management, and predictors.Use of recombinant factor VIIa (NovoSeven®) in 8 patients with ongoing life-threatening bleeding treated with fondaparinux
P2860
Q33392895-68889B38-DF21-4B47-B583-F0E876C07134Q33750028-84F3843B-0203-4785-8710-74BF3363C2B9Q33770832-36321740-72EA-4517-BF5D-23A7A3877F69Q35079519-F36348A4-5567-4546-855F-4B175C2D860EQ35688509-9BD642D1-0BB9-4461-8F3D-59EF35E79DDDQ36988677-EABC60B0-104C-4B3B-A914-345ED8E923C0Q37148386-80350EFE-F459-4025-BF19-F6A3DB241A65Q37175915-29CF82A3-4367-4DFA-A558-75BA5236A4A5Q37357064-3EBA8ED6-CF70-4084-8FA9-FD6C3AAA6D94Q37532491-457A7713-22B1-4657-A519-744E20B26A99Q37792099-031E4874-B3F6-49DB-8661-77EA0DCC4F56Q38027576-02D07B6D-CA57-4BB4-B238-B83B7605703AQ39096124-6FB626D8-FDAA-4345-828F-51A0C8C27B5DQ43847029-86532961-B42B-4347-A7DA-3BDBAE32E5D2Q47105087-7F2045D2-73CA-4F8E-8EDF-26D8F4E30689Q47658855-04C98E35-FF1E-4D88-8F73-A6482ABD43D2Q53088900-260D4402-B5CB-4CDF-8CDD-E986736A6BB9Q58088700-AD09F0AD-7D3D-4F56-A97D-30F79D20E9A9
P2860
Assessment of bleeding events in clinical trials--proposal of a new classification
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Assessment of bleeding events in clinical trials--proposal of a new classification
@ast
Assessment of bleeding events in clinical trials--proposal of a new classification
@en
Assessment of bleeding events in clinical trials--proposal of a new classification
@nl
type
label
Assessment of bleeding events in clinical trials--proposal of a new classification
@ast
Assessment of bleeding events in clinical trials--proposal of a new classification
@en
Assessment of bleeding events in clinical trials--proposal of a new classification
@nl
prefLabel
Assessment of bleeding events in clinical trials--proposal of a new classification
@ast
Assessment of bleeding events in clinical trials--proposal of a new classification
@en
Assessment of bleeding events in clinical trials--proposal of a new classification
@nl
P3181
P1476
Assessment of bleeding events in clinical trials--proposal of a new classification
@en
P2093
Victor L Serebruany
P304
P3181
P356
10.1016/J.AMJCARD.2006.07.091
P407
P50
P577
2007-01-15T00:00:00Z